欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号MT/H/0468/002
药品名称Apixaban Combino Pharm 5 mg film-coated tablets
活性成分
    • APIXABAN 5.0 mg
剂型Film-coated tablet
上市许可持有人Combino Pharm (Malta) Ltd HF60 Hal Far Industrial Estate Hal Far BBG3000, Malta
参考成员国 - 产品名称Malta (MT)
Apixaban Combino Pharm 5 mg film-coated tablets
互认成员国 - 产品名称
    • Hungary (HU)
    • Sweden (SE)
    • Czechia (CZ)
      Apixaban Teva CZ
    • Bulgaria (BG)
      Apixaban Teva
    • Finland (FI)
    • Spain (ES)
    • Germany (DE)
      Apixaban Combino Pharm 5 mg Filmtabletten
    • Ireland (IE)
    • Belgium (BE)
    • Portugal (PT)
    • France (FR)
    • Norway (NO)
    • Estonia (EE)
    • Poland (PL)
    • Italy (IT)
    • Luxembourg (LU)
    • Slovenia (SI)
    • Lithuania (LT)
    • Croatia (HR)
    • Netherlands (NL)
    • Denmark (DK)
    • Slovakia (SK)
    • Latvia (LV)
    • Romania (RO)
      Apixaban Teva 5 mg comprimate filmate
    • Austria (AT)
    • Iceland (IS)
许可日期2021/02/08
最近更新日期2024/03/21
药物ATC编码
    • B01AF02 apixaban
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase